fashion -WSS

fashion

author：comprehensive 2025-09-30 16:29:08 - browse：47283

A judge ruled that Welsh Carson won't have to face antitrust allegations about its anesthesiology practice. Adobe

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia Partners, still must face the agency’s antitrust case, a judge ruled last week.

The FTC alleged last year that the anesthesiology network monopolized markets in Texas to drive up prices, but took the unusual step of attaching Welsh Carson as a defendant with USAP. Dismissing Welsh Carson from the case was a victory for the private equity firm and, more broadly, other firms worried that the Biden administration would try to hold them responsible for anything their portfolio companies do.

But the allegations against USAP didn’t disappear, which will keep up scrutiny on companies that have made a push to acquire numerous physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： After a decade, new Gardasil ad campaign gets it (mostly) right

entertainment

WSS

In rare move, senator releases unverified FBI source report alleging Biden bribe

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

US jobless claims fall again as labor market continues to flash strength

There’s a way to spot data fakery. All journals should be using it

Why drug prescriptions should include diagnoses

The science behind Janet Jackson's pregnancy at 49

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

explore

In Memoriam: Notable people who died in 2023

CDC concerned about possible undetected monkeypox spread in U.K.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Apple is now the first public company to be valued at $3 trillion

Sanders wants to replace patents with prizes for drug inventions

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

After affirmative action ruling, medical educators look to 'holistic review'

Ask STAT: What do you want to know about ChatGPT in medicine?

focus

Death of patient in Alzheimer’s trial raises question of possible risks

US jobless claims fall again as labor market continues to flash strength

The science behind Janet Jackson's pregnancy at 49

A new ‘biological computer' targets cancer while sparing healthy cells

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Sanders wants to replace patents with prizes for drug inventions

entertainment

knowledge

entertainment

focus